<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Ondansetron - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Ondansetron</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">GI</div>
      <h1>Ondansetron</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Ondansetron 4mg Tablets</li>
          <li>Ondansetron 2mg/mL Injection 2mL</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Nausea/vomiting (general, adult)</strong></p>
        <ul>
          <li>PO: 4 mg once; consider repeat dosing only if allowed by your local protocol/medical direction</li>
          <li>IV/IM/SC: 4 mg (common); administer IV slowly (e.g., over ~2â€“5 minutes) to reduce adverse effects</li>
        </ul>
        <p><strong>Post-op / medication-related nausea</strong></p>
        <ul>
          <li>Same approach: 4 mg PO or 4 mg parenteral commonly used; tailor to clinical context</li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Nausea and vomiting (multiple causes; use when clinically appropriate)</li>
          <li>Prevention/treatment of significant nausea that interferes with hydration/PO meds</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Concomitant apomorphine is contraindicated (severe hypotension/LOC risk)</li>
          <li>QT prolongation risk: caution with known long QT, significant electrolyte abnormalities, or other QT-prolonging drugs</li>
          <li>Severe hepatic impairment: dosing limits may apply (protocol/monograph dependent)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>PO tablet: swallow with water</li>
          <li>IV: give slowly; ensure line patency; flush per local practice</li>
          <li>Avoid rapid IV push if protocol advises slower administration</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Symptom response (nausea/vomiting frequency), hydration status</li>
          <li>If risk factors: consider ECG monitoring and address electrolytes when possible</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Headache</li>
          <li>Constipation</li>
          <li>QT prolongation (rare but important), dizziness</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Useful "function-restoring" med: enables oral fluids/meds and reduces dehydration risk at sea</li>
          <li>If severe ongoing vomiting: reassess for surgical/critical causes and plan escalation/evac early</li>
          <li>Consider motion-related triggers; pair with non-pharm measures when appropriate</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <p><strong>Video:</strong></p>
        <ul>
          <li><a href="https://youtube.com/watch?v=RODPP3S8AoA" target="_blank">Ondansetron nursing considerations / administration pearls</a></li>
        </ul>
        <p><strong>Documentation:</strong></p>
        <ul>
          <li><a href="https://pdf.hres.ca/dpd_pm/00052952.PDF" target="_blank">Health Canada product monograph: ondansetron</a></li>
          <li><a href="https://handbook.bcehs.ca/drug-monographs/ondansetron/" target="_blank">BC EHS practical monograph</a></li>
          <li><a href="https://myhealth.alberta.ca/Health/medications/Pages/conditions.aspx?hwid=fdb8296" target="_blank">ODT-style administration instructions (patient-facing)</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
